In conclusion, our study identified a key immune signaling pathway involved in the regulation of calprotectin production by neutrophils in response to the S protein of SARS-CoV-2, and further revealed potential therapeutic molecules which can be targeted to dampen the over-expression of calprotectin associated with severe cases of COVID-19. The gene discussed is PROS1; the disease is COVID-19.